1,4-diacetylpiperazine-2,5-dione

Suppliers

Names

[ CAS No. ]:
3027-05-2

[ Name ]:
1,4-diacetylpiperazine-2,5-dione

[Synonym ]:
1,4-diacetyltetrahydro-2,5-pyrazinedione
N,N'-diacetyl-2,5-diketopiperazine
1,4-Diacetyl-piperazine-2,5-dione
1,4-Diacetyl-2,5-piperazinedione
1,4-Diacetyl-2,5-dioxopiperazine
1,4-diacetyl-2,5-diketopiperazine
N,N'-Diacetylglycine Anhydride
2,5-Piperazinedione, 1,4-diacetyl-
CBBKKVPJPRZOCM-UHFFFAOYSA
N,N'-diacetyl-2,5-piperazinedione
N,N'-Diacetyl-2,5-dioxopiperazine
N,N'-diacetyl-cyclo(Gly-Gly)
1,4-diacetylpiperazine-2,5-dione

Chemical & Physical Properties

[ Density]:
1.4±0.1 g/cm3

[ Boiling Point ]:
424.4±38.0 °C at 760 mmHg

[ Melting Point ]:
99-100ºC

[ Molecular Formula ]:
C8H10N2O4

[ Molecular Weight ]:
198.176

[ Flash Point ]:
216.6±19.1 °C

[ Exact Mass ]:
198.064056

[ PSA ]:
74.76000

[ LogP ]:
-0.80

[ Vapour Pressure ]:
0.0±1.0 mmHg at 25°C

[ Index of Refraction ]:
1.526

MSDS

Click to get detail MSDS

Safety Information

[ Symbol ]:

GHS07

[ Signal Word ]:
Warning

[ Hazard Statements ]:
H302-H315-H317-H319

[ Precautionary Statements ]:
P280-P305 + P351 + P338

[ Risk Phrases ]:
R36/37/38

[ Safety Phrases ]:
S26-S36-S37-S39

[ RIDADR ]:
NONH for all modes of transport

[ HS Code ]:
2933599090

Synthetic Route

Click to get detail synthetic route

Customs

[ HS Code ]: 2933599090

[ Summary ]:
2933599090. other compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%

Related Compounds

  • 1,4-dibenzylpiperazine-2,5-dione
  • 1,4-Dioxane-2,5-dione, 3, 6-diethyl-
  • 1-(4-propoxyphenyl)pyrrole-2,5-dione
  • 1-(4-azidophenyl)pyrrole-2,5-dione
  • 1-(4-iodoanilino)pyrrole-2,5-dione
  • 1-(4-phenylbutyl)pyrrole-2,5-dione
  • 2-(2-(4-(4-methoxyphenyl)piperazin-1-yl)-2-oxoethyl)-6-phenyl-[1,2,4]triazolo[4,3-b]pyridazin-3(2H)-one
  • 2-(2-(4-(2-fluorophenyl)piperazin-1-yl)-2-oxoethyl)-6-phenyl-[1,2,4]triazolo[4,3-b]pyridazin-3(2H)-one
  • 2-(2-(4-(4-fluorophenyl)piperazin-1-yl)-2-oxoethyl)-6-phenyl-[1,2,4]triazolo[4,3-b]pyridazin-3(2H)-one
  • n-(4-Carbamimidoylbenzyl)-2-[1-(3-methoxybenzenesulfonylamino)-4-methyl-2-oxo-1,2-dihydropyridin-3-yl]acetamide
  • 6-(4-chlorophenyl)-2-(2-oxo-2-(4-phenylpiperazin-1-yl)ethyl)-[1,2,4]triazolo[4,3-b]pyridazin-3(2H)-one
  • N-cyclohexyl-2-[2-(5-ethyl-1,3,4-oxadiazol-2-yl)-1H-pyrrol-1-yl]acetamide
  • (4S)-5-[[(2S,5S,8S,11R,12S,15S,18S,21R)-15-[3-(diaminomethylideneamino)propyl]-21-hydroxy-5-[(4-hydroxyphenyl)methyl]-4,11-dimethyl-2-(2-methylpropyl)-3,6,9,13,16,22-hexaoxo-8-propan-2-yl-10-oxa-1,4,7,14,17-pentazabicyclo[16.3.1]docosan-12-yl]amino]-4-(hexanoylamino)-5-oxopentanoic acid
  • N-(4-Aminophenyl)-2-[(2-bromophenyl)thio]propanamide
  • 1-(2-Ethylbutanoyl)-4-{[2-(piperidin-1-ylcarbonyl)phenoxy]methyl}piperidine
  • 6-(4-chlorophenyl)-2-(2-(4-(4-fluorophenyl)piperazin-1-yl)-2-oxoethyl)-[1,2,4]triazolo[4,3-b]pyridazin-3(2H)-one
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.